La Administración de Alimentos y Medicamentos de Estados Unidos (FDA, por sus siglas en inglés) autorizó el miércoles la píldora contra la COVID-19 de Pfizer, un paso importante en la lucha contra la pandemia ya que millones de personas podrán tener acceso al tratamiento. (Fuente: AFP)
:quality(75)/cdn.jwplayer.com/v2/media/LsRUFvD5/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/Sn0u4NP3/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/dYzvyk19/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/RIJFCZvF/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/j6VJHJno/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/2mYqd7DO/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/ksyUfpCJ/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/r5QyEIqX/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/N1W5L0Zs/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/GNEh4G4W/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/ZJRMYQTLGVFTTCQZDWD6JUNJ34.png)
:quality(75)/cdn.jwplayer.com/v2/media/T4n0udCH/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/COHF432VHJA33DZIPRNACAW3BU.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/LsRUFvD5/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/RIJFCZvF/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/j6VJHJno/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/NDT2QQOACNDPXGC3UACYNN6CUA.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/dYzvyk19/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/swVcW6Gj/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/Z652MUIDURA5HM6EQJXHHY74CY.png)
:quality(75)/cdn.jwplayer.com/v2/media/PwCA0Q5Y/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/koNs9MA2/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/6bLTGi5d/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/KgeU8b6Q/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/a6mwPQ4X/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/X3PAJUVAAFHRXHUYV5TON7UAAY.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/juAVPNx9/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/yksVgSj8/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/wXUo9jVU/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/c0S03whF/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/azLadx4o/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/FQ5XSTUGQ5DI3DYDC3MUSLQL6A.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/9a1H4G0a/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/yOEdb2ys/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/JDVYxTbd/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/LIy1dI2W/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/Xv8iJGpA/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/JW2JBE7IBZEY5NR2VH4KVTPGZ4.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/42WZKDIDGVA6VKQDF75376W2CA.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/ENCJ6JEIFZHT5E6UXK3KZ5RCUU.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/UZ27WLDNBFBCPCMLG42DQCNJYA.png)